Speakers

Hugo Lindqvist builds and maintains the analysis tooling a dozen research groups depend on, and spends most of his time making other people’s work reproducible.

Yuki Tanaka-Reid leads a translational medicine group whose work spans early-phase trial design and the health-economic case for adopting what those trials find. She has chaired the congress scientific committee twice.